DRTSALPHA TAU MEDICAL LTD
DRTS
ALPHA TAU MEDICAL LTD1,575
Mkt Cap
$600.26MVolume
3,590.0052W High
$8.6052W Low
$2.30PE Ratio
-13.33DRTS Fundamentals
Price
$7.04Prev Close
$6.84Open
$6.8850D MA
$6.93Beta
0.72Avg. Volume
320,523.56EPS (Annual)
-$0.529P/B
8.04Rev/Employee
$0.00$335.70
Earnings Recap
Alpha Tau Medical expects to incur substantial losses and increasing expenses for the foreseeable future, requiring significant additional funding for clinical trials, manufacturing expansion, and commercialization efforts over the next several years.
Bullish
Alpha Tau Medical's novel Alpha DaRT technology shows promising interim clinical results and FDA Breakthrough Device Designations, supported by expanding manufacturing capabilities and a robust patent portfolio.
Bearish
Alpha Tau Medical faces significant losses, no revenue, and substantial funding needs for clinical development, coupled with unpredictable regulatory hurdles and supply chain risks for its novel Alpha DaRT technology.